Neonatology

Original Paper

Hyaluronan in the Human Neonatal Lung: Association with Gestational Age and Other Perinatal Factors

Johnsson H.a · Eriksson L.b · Gerdin B.c · Hällgren R.d · Sedin G.a

Author affiliations

Departments of aWomen’s and Children’s Health, bGenetics and Pathology, cSurgery and dRheumatology, Uppsala University, Uppsala, Sweden

Related Articles for ""

Biol Neonate 2003;84:194–201

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: September 24, 2003
Issue release date: October 2003

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstract

The aim of this study was to determine the influence of gestational age at birth, postnatal age, specific complications and methods of treatment on the lung hyaluronan concentration in infants. Lung samples and clinical records from 117 infants who died 0–228 days (32 weeks) after preterm or term birth were studied. The lung hyaluronan concentration at death was most strongly associated with the gestational age at birth, an association best described by an exponential function with a negative power coefficient. After adjustments for gestational age, the lung hyaluronan concentration also correlated significantly with birth weight, weight at death, the wet-to-dry lung weight ratio and specific staining for hyaluronan in the pleura. Intrauterine infection was also associated with a significantly higher lung hyaluronan concentration.

© 2003 S. Karger AG, Basel




Related Articles:


References

  1. Fraser JRE, Laurent TC: Hyaluronan; in Comper WD (ed): Extracellular Matrix. Amsterdam, Harwood Academic Publishers, 1996, vol 2: Molecular Components and Interactions, pp 141–199.
  2. Brandt R, Hedlöf E, Asman I, Bucht A, Tengblad A: A convenient radiometric assay for hyaluronan. Acta Otolaryngol (Stockh) 1987;suppl 442:31–35.
  3. Allen SJ, Sedin G, Jonzon A, Wells AF, Laurent TC: Lung hyaluronan during development: A quantitative and morphological study. Am J Physiol 1991;260:H1449–H1454.
  4. Johnsson H, Eriksson L, Jonzon A, Laurent TC, Sedin G: Lung hyaluronan and water content in preterm and term rabbit pups exposed to oxygen or air. Pediatr Res 1998;44:716–722.
  5. Johnsson H, Eriksson L, Sedin G: Antenatal betamethasone administration decreases the lung hyaluronan concentration in preterm rabbit pups. Pediatr Res 2001;49:566–571.
  6. Juul SE, Kinsella MG, Wight TN, Hodson WA: Alterations in nonhuman primate (M. nemestrina) lung proteoglycans during normal development and acute hyaline membrane disease. Am J Respir Cell Mol Biol 1993;8:299–310.
  7. Juul SE, Kruger RC, Scofield L, Hershenson MB, Schwartz NB: Hyperoxia alone causes changes in lung proteoglycans and hyaluronan in neonatal rat pups. Am J Respir Cell Mol Biol 1995;13:629–638.
  8. Johnsson H, Eriksson L, Sedin G: Antenatal terbutaline administration decreases the lung hyaluronan concentration in preterm rabbit pups. Biol Neonate 2001;80:173–178.
  9. Schmid K, Grundboeck-Jusco J, Kimura A, Tschopp FA, Zollinger R, Binette JP, Lewis W, Hayashi S: The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in concentration of these macromolecules during development and aging. Biochim Biophys Acta 1982;716:178–187.
  10. Sedin G, Gerdin B, Johnsson H, Jonzon A, Eriksson L, Hällgren R: Hyaluronan (HA) and water content in the lung of preterm and term infants who died just before birth or within 24 h after birth (abstract). Biol Neonate 1994;66:167.
  11. Sedin G, Gerdin B, Johnsson H, Jonzon A, Eriksson L, Hällgren R: Hyaluronan and water content in the lung of preterm and term infants who died less than 24 h after birth (abstract). Pediatr Res 1994;36:37A.
  12. Nettelbladt O, Tengblad A, Hällgren R: Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis. Am J Physiol 1989;257:L379–L384.
  13. Brandt R, Hedlöf E, Asman I, Bucht A, Tengblad A: A convenient radiometric assay for hyaluronan. Acta Otolaryngol (Stockh) 1987;suppl 442:31–35.
  14. Ripellino JA, Klinger MM, Margolis RU, Margolis RK: The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections. J Histochem Cytochem 1985;33:1060–1066.
  15. The International Neonatal Network: The CRIB (clinical risk index for babies) score: A tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 1993;342:193–198.
  16. Juul SE, Kinsella MG, Jackson JC, Truog WE, Standaert TA, Hodson WA: Changes in hyaluronan deposition during early respiratory distress syndrome in premature monkeys. Pediatr Res 1994;35:238–243.
  17. Pringle KC: Human fetal lung development and related animal models. Br J Obstet Gynecol 1986;29:502–513.
  18. Johnsson H, Heldin P, Sedin G, Laurent TC: Hyaluronan production in vitro by fetal lung fibroblasts and epithelial cells exposed to surfactants or N-acetylcysteine. Uppsala J Med Sci 1997;102:199–210.
  19. Gerdin B, Hällgren R: Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med 1997;242:49–55.
  20. Juul SE, Kinsella MG, Truog WE, Gibson RL, Redding GJ: Lung hyaluronan decreases during group B streptococcal pneumonia in neonatal piglets. Am J Crit Care Med 1996;153:1567–1570.
  21. Jackson JC, Chi EY, Wilson CB, Truog WE, Teh EC, Hodson WA: Sequence of inflammatory cell migration into lung during recovery from hyaline membrane disease in premature monkeys. Am Rev Respir Dis 1987;135:937–940.
  22. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer CP: Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712–718.
  23. Davies JM, Dickerson B, Metlay L, Penney DP: Differential effects of oxygen and barotrauma on lung injury in the neonatal piglet. Pediatr Pulmonol 1991;10:157–163.
  24. Cherukupalli K, Larson JE, Rotschild A, Thurlbeck WM: Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;22:215–229.
  25. Sedin G, Bogner P, Berényi E, Repa I, Nyúl Z, Sulyok E: Lung water and proton magnetic resonance relaxation in preterm and term rabbit pups: Their relation to tissue hyaluronan. Pediatr Res 2000;48:554–559.
  26. Bland RD: Formation of fetal lung liquid and its removal near birth; in Polin RA, Fox WW (eds): Fetal and Neonatal Physiology, ed 2. Philadelphia, Saunders, 1998, pp 1047–1054.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: September 24, 2003
Issue release date: October 2003

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP